Revolutionizing Healthcare Through

the Power of AI
Our mission is to improve the delivery of healthcare worldwide, help people live longer and healthier lives, and deliver superior returns to our investors who share our vision.

Our Mission

Improve delivery of healthcare to everyone on the planet.

Harnessing AI for precise diagnoses and enhanced treatment outcomes, we aim to make a lasting impact on global patient care.

Help people live longer, healthier, more productive lives.

By accelerating AI-driven drug discovery and personalized healthcare guidance, we foster wellbeing and disease prevention.

Deliver superior returns to investors believing in Leap AI vision.

Our strategic AI innovations in healthcare promise to maximize investment value and drive substantial growth.

Who Are We and What Motivates Us

The shift from traditional venture investing to venture studios mirrors the early 2000s' move from waterfall to agile - a faster, more cost-efficient approach to tackling early, uncertain ideas.
Motivated by this, we founded Leap AI in the fall of 2023. We are combining our collective expertise and passion to apply the studio model to the intersection of Gen AI and biotech/healthcare innovation.
Our winning formula is based on a unique mix of talent and investments in our proprietary healthcare AI platforms and a rigorous process that enables us to manage all phases of venture creation and execution.

Intellectual Curiosity

We are a team of professionals with a blended mix of advanced degrees in science, technology and business. We pride ourselves in having an entrepreneurial mindset all driven by our intellectual and scientific curiosity.

Students of Innovation

We consider ourselves ‘students of innovation,’ having spent a significant part of our careers in product development, R&D, deep tech, and innovation in a wide variety of institutions, ranging from government labs, corporate R&D, innovation think tanks, digital software agencies, tech consulting, and startups. We are motivated by translating emerging science and deep tech into real outcomes that create a positive impact in the world.

Diverse Experience

Our collective experience gives us a unique vantage point in observing shifts in innovation paradigms and in managing innovation effectively, consistent with those emerging trends.

Venture Studio Model

We deeply believe in the studio model because it challenges existing venture creation models and has the potential to fundamentally change ‘the unit economics of venture creation,’ making it capital efficient and more impactful.

Meet Our Team

Chief Executive Officer

Tolga Kurtoglu, PhD

Tolga, the former CTO of HP and CEO at Xerox PARC, brings over 20 years of tech industry experience. He has transitioned more than 40 innovations to the market through various commercialization strategies, including spin-offs and partnerships with major corporations. He founded PARC Refinery, a venture studio pushing the boundaries of Enterprise AI, IoT, and clean tech. He co-led HP's incubation efforts, creating edge computing, cybersecurity, and life sciences ventures. As a Board Member at Omidyar Network, he advocates for ethical GenAI and provides advice to AI startups.
MSc Carnegie Mellon; PhD, Mechanical Engineering, Univ. of Texas-Austin
Chief Financial Officer

Ali Paasimaa

Ali is a senior executive and entrepreneur with 20+ years of leadership experience ranging from startups to Fortune 100. Former US CEO & Chair, EVP Strategy and Board Advisor at Reaktor, global software agency with a Venture Studio of 30 companies. Chair of IPO’ed LP holdings. Managing Director PwC US Digital Strategy and EY Private Equity Tech Advisory Leader. Co-founder, CFO and Chair of a D2C business with 120K+ customers. Engineering leader at a software startup with $100M funding, acquired by IBM.
MSc Business Economics & Computer Science, Univ. of Helsinki
Chief Technology Officer

Serdar Uckun, MD, PhD

Serdar is an experienced entrepreneur specializing in genomics, biotech, systems engineering, artificial intelligence, and data science. With over 20 years of management experience, he has led international mergers and acquisitions and achieved over $40M in new business wins. His entrepreneurial ventures include co-founding Leap AI; Novity, a physics-based predictive maintenance platform for manufacturing; and CyDesign Labs, a company that pioneered a cloud platform for model-based design optimization.
MD, Medicine, Ege University; MSc, Biomedical Engineering, Boğaziçi University; PhD, Biomedical Engineering, Vanderbilt University; Postdoc, Computer Science and AI, Stanford University
Head of AI

Mikko Koskinen, PhD

Mikko was the Data & AI Competence Area Leader at Reaktor, a global software agency. A passionate AI technologist, Mikko is a renowned thought leader and frequent lecturer & guest speaker in academia and media on the impact and ethics of using Generative AI. Mikko has been a senior advisor in data & AI strategy for business and government leadership and spearheaded AI transformation for multiple industries.
MSc Chemistry, Univ. of Stockholm; PhD Neuroscience, Univ. of Helsinki;
Chief Commercial Officer

Can "John" Akgun, PhD

Can (pronounced “John”) is a serial entrepreneur with 15+ years experience launching, building, and leading healthcare ventures. Can held Business Development and Commercial Executive roles for SPEAG, Zurich MedTech, Imbio, LLC and Flywheel Exchange. He served as Head of Portfolio Development for Invenshure, a biotech venture studio focused on building tech and biotech companies (10 companies launched, 3 exits to date). Can is an internationally published researcher, holds multiple patents and is a thought leader in medical imaging and computational techniques including AI/ML.
MSc Electrical Engineering; PhD Biomedical Engineering, Univ. of Minnesota
Head of Product

Patrycja Vasilyev Missiuro, PhD

Product management and strategy professional with over a decade of experience in the healthcare and life sciences tech industry. Senior roles at Philips, Oracle and ConcertAI shaping and delivering innovative software solutions for digital trials/drug discovery. Expertise in strategic problem-solving, AI thought leadership, go-to-market execution, team management, client partnerships and regulatory compliance. Skilled in driving business growth through strong leadership.
MS Computer Science and Electrical Engineering; PhD Computational Biology, MIT
Head of UX

James Glasnapp, DrPH

James founded Tappr, LLC, providing market-ready insights via cutting-edge research tools. Seasoned innovation researcher with global experience across major corporations like Sony, P&G, Panasonic, PepsiCo, DoorDash, Netflix and Alcon. Commercialized leading-edge concepts at Xerox PARC, bringing venture studio expertise. Spearheaded pharmaceutical design research resulting in a transformative over-the-counter device. Featured in CMS Wire, TechCrunch, VentureBeat.
BS Advertising, Univ. of Kansas; MPH & DrPH., UC Berkeley
VP of Strategic Partnerships

Tim Curley

Tim Curley is a dynamic growth builder, driving strategic initiatives across business development, strategic partnerships, and corporate new business ventures. Tim served as Head of IoT New Business Ventures at the Palo Alto Research Center (PARC, a Xerox Company), and Senior Director of Business and Partnership Development. Prior to PARC, Tim held key business development and partnership roles at Nortel Networks, MegaChips Corporation (IPO), Nogatech (IPO), Sanyo Corporation, and United States Air Force.
MBA in Strategy from Pepperdine Graziadio Business School, BSc in Business Management from Menlo College.
Advisory Board Member

Geoffrey Rutledge, MD, PhD

Dr. Geoffrey Rutledge is a renowned physician, entrepreneur, and digital health expert with over 30 years of experience in the healthcare sector. He is the co-founder and Chief Medical Officer of HealthTap, a platform that delivers quality healthcare through mobile devices worldwide. He created "Dr. A.I.", the generative-AI based virtual physician assistant that is now helping doctors and their patients on HealthTap. He has held various leadership roles in the healthcare industry and has made significant contributions to the field of medical informatics.
PhD Medical Computing, Stanford; ABIM Internal Medicine, UC San Diego, MD & BSc Biology, McGill.
Advisory Board Member

Danny Cunagin

Danny Cunagin is a serial tech entrepreneur with 20+ years experience who’s the co-founder & co-managing director of Invenshure, a biotech venture studio that was launched in 2012. At Invenshure, Danny has overseen the creation of high-growth ventures such as MEKanistic Therapeutics, Exosite, and Imbio, LLC. Danny’s approach to problem-solving blends intuitive design thinking with engineering rigor. His unruffled approach navigates deeply through problems and opportunities, managing them from the bench through the boardroom.
BSME in Mechanical, Biomedical Engineering from the University of Kentucky.
Advisory Board Member

Usama Fayyad, PhD

Dr. Usama Fayyad, globally recognized as an AI and data expert, is the Chairman & Founder of Open Insights. His current role as the Inaugural Director of the Institute for Experiential AI at Northeastern University. His strategic leadership is demonstrated by his roles as Chief Data Officer at Barclays Bank and being the first to hold the Chief Data Officer title when Yahoo! acquired his second startup out of Microsoft. A Ph.D. holder from The University of Michigan, he has numerous technical articles and patents. As an AAAI & ACM Fellow, his tech innovation experience is remarkable.
B.S.E.’s in Computer and Electrical Engineering, M.S.E. in Computer Engineering, M.Sc. in Mathematics, and Ph.D. in Computer Science & Engineering, Univ. of Michigan.